Related Experiment Videos
Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation
Gerard D'Angelo1, Leonard P Adam
1Boston Biomedical Research Institute, Watertown, Massachusetts 02472, USA. gerard.dangelo@bms.com
Abstract:
Phosphorylation of the actin-associated protein caldesmon (CaD) by extracellular signal-regulated kinases (ERK1/2) is purported to participate in force maintenance by vascular smooth muscle. We examined the interrelationship among ERK1/2 activity, phosphorylation of the high molecular weight isoform of CaD (h-CaD) and the 20-kDa myosin light chain (LC(20)), and isometric force in strips of porcine carotid artery stimulated with endothelin-1 (ET-1; 50 nM). After an initial delay, ERK1/2 activity increased in parallel with ET-1-mediated force; h-CaD phosphorylation increased modestly. 2-(2'-Amino-3'-methoxyphenyl)-ox-anaphthalen-4-one (PD-098059; 50 microM), an ERK1/2 kinase inhibitor, significantly reduced basal ERK1/2 activity within 1 h, but only partially attenuated h-CaD phosphorylation at 3 h. The mechanisms underlying the temporal dissociation of ERK1/2 activity from h-CaD phosphorylation are unknown, but include the possibility that a kinase other than ERK1/2 phosphorylates h-CaD or, more likely, that phosphate turnover in h-CaD is very slow. PD-098059 partially inhibited the development of ET-1-stimulated force only in Ca(2+)-replete physiological saline solution, primarily by reducing LC(20) phosphorylation, yet had no effect on myosin light chain kinase in vitro. These inhibitory effects were most evident during the early phase of force production. The inhibitory effect of PD-098059 on force could not be correlated with a corresponding effect on ERK1/2-mediated h-CaD phosphorylation because force in arterial strips stimulated with ET-1 in the absence or presence of PD-098059 tended to approximate each other over time despite significant differences in the level of h-CaD phosphorylation. Force and LC(20) phosphorylation in response to KCl depolarization were unaffected by PD-098059. These results show that ERK1/2 may regulate force in arterial smooth muscle, but suggest that the mechanism for this effect is by inhibiting LC(20) phosphorylation.
Insights
Extracellular signal-regulated kinases (ERK1/2) may regulate vascular smooth muscle force by inhibiting 20-kDa myosin light chain (LC(20)) phosphorylation, not by affecting caldesmon (CaD) phosphorylation.
Area of Science:
- Vascular smooth muscle physiology
- Cell signaling pathways
- Protein phosphorylation
Background:
- Extracellular signal-regulated kinases (ERK1/2) are implicated in vascular smooth muscle (VSM) force maintenance.
- Caldesmon (CaD) phosphorylation by ERK1/2 is a proposed mechanism for force regulation in VSM.
Purpose of the Study:
- To investigate the relationship between ERK1/2 activity, caldesmon (h-CaD) and 20-kDa myosin light chain (LC(20)) phosphorylation, and isometric force in porcine carotid artery.
- To determine the role of ERK1/2 in endothelin-1 (ET-1) mediated force production and associated signaling.
Main Methods:
- Isometric force measurements in porcine carotid artery strips.
- Stimulation with endothelin-1 (ET-1) and potassium chloride (KCl).
- Western blot analysis for phosphorylated h-CaD and LC(20), and ERK1/2 activity assays.
- Inhibition of ERK1/2 using PD-098059.
Main Results:
- ET-1 increased VSM force, ERK1/2 activity, and modestly increased h-CaD phosphorylation.
- PD-098059 partially inhibited ET-1-stimulated force, primarily by reducing LC(20) phosphorylation, with minimal effect on h-CaD phosphorylation.
- ERK1/2 inhibition did not affect force or LC(20) phosphorylation induced by KCl depolarization.
Conclusions:
- ERK1/2 signaling may regulate vascular smooth muscle force, but likely through mechanisms independent of direct h-CaD phosphorylation.
- The primary mechanism appears to involve the inhibition of LC(20) phosphorylation.
- Temporal dissociation between ERK1/2 activity and h-CaD phosphorylation suggests complex regulation or slow phosphate turnover in h-CaD.